Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehmet Kanbay

Showing results (1-10 of 513) with videos related to

Pageof 52
Sort By:
NDT Plus|May 8, 2015
Bone morphogenic protein-7: a new prognostic marker for acute kidney injury?Mehmet Kanbay, Adrian Covic
The New England Journal of Medicine|April 6, 2018
Hyperthermic Intraperitoneal Chemotherapy in Ovarian CancerBaris Afsar, Mehmet Kanbay
Journal of Clinical Hypertension (Greenwich, Conn.)|April 11, 2015
Reply to: Hemodynamic and Arterial Stiffness Parameters in Ambulatory Blood Pressure Phenotypes and the Clinical Scenario of Polypharmacy and ComorbiditiesBaris Afsar, Mehmet Kanbay
Clinical Kidney Journal|January 17, 2022
The assessment of hypertension in kidney transplant patients: time to change our approach?Atalay Demiray, Mehmet Kanbay
Journal of Clinical Hypertension (Greenwich, Conn.)|December 3, 2014
Are all β-blockers the same? Nebivolol vasodilator properties and evidence for relevance in treatment of hypertensionMehmet Kanbay, Baris Afsar
Clinical Kidney Journal|July 27, 2022
Visit-to-visit blood pressure variability and risk of dementia in chronic kidney disease patients: why are blood pressure changes so important in cognitive functions?Furkan Yavuz, Mehmet Kanbay
Journal of Clinical Hypertension (Greenwich, Conn.)|February 24, 2015
A new risk factor for cardiovascular disease and associated risk factors: educationNathan Bertelsen, Mehmet Kanbay
Clinical Kidney Journal|August 31, 2017
Revisiting angioplasty for renovascular hypertensionAlan A Sag, Mehmet Kanbay
Angiology|May 11, 2017
Reply to: Uric Acid and Contrast-Induced Nephropathy: Diagnostic Marker, Therapeutic Target, or Innocent Bystander?Dilek O Sahan, Mehmet Kanbay
Clinical Kidney Journal|September 26, 2022
Increase in the global burden of chronic kidney disease: might it be attributable to air pollution?Sidar Copur, Duygu Ucku, Mehmet Kanbay
Pageof 52

Showing results (1-10 of 513) with videos related to

Sort By:
Pageof 52
NDT Plus|May 8, 2015
Bone morphogenic protein-7: a new prognostic marker for acute kidney injury?Mehmet Kanbay, Adrian Covic
The New England Journal of Medicine|April 6, 2018
Hyperthermic Intraperitoneal Chemotherapy in Ovarian CancerBaris Afsar, Mehmet Kanbay
Journal of Clinical Hypertension (Greenwich, Conn.)|April 11, 2015
Reply to: Hemodynamic and Arterial Stiffness Parameters in Ambulatory Blood Pressure Phenotypes and the Clinical Scenario of Polypharmacy and ComorbiditiesBaris Afsar, Mehmet Kanbay
Clinical Kidney Journal|January 17, 2022
The assessment of hypertension in kidney transplant patients: time to change our approach?Atalay Demiray, Mehmet Kanbay
Journal of Clinical Hypertension (Greenwich, Conn.)|December 3, 2014
Are all β-blockers the same? Nebivolol vasodilator properties and evidence for relevance in treatment of hypertensionMehmet Kanbay, Baris Afsar
Clinical Kidney Journal|July 27, 2022
Visit-to-visit blood pressure variability and risk of dementia in chronic kidney disease patients: why are blood pressure changes so important in cognitive functions?Furkan Yavuz, Mehmet Kanbay
Journal of Clinical Hypertension (Greenwich, Conn.)|February 24, 2015
A new risk factor for cardiovascular disease and associated risk factors: educationNathan Bertelsen, Mehmet Kanbay
Clinical Kidney Journal|August 31, 2017
Revisiting angioplasty for renovascular hypertensionAlan A Sag, Mehmet Kanbay
Angiology|May 11, 2017
Reply to: Uric Acid and Contrast-Induced Nephropathy: Diagnostic Marker, Therapeutic Target, or Innocent Bystander?Dilek O Sahan, Mehmet Kanbay
Clinical Kidney Journal|September 26, 2022
Increase in the global burden of chronic kidney disease: might it be attributable to air pollution?Sidar Copur, Duygu Ucku, Mehmet Kanbay
Pageof 52